Phase II Study of Gemcitabine and Bevacizumab As First-Line Treatment in Taxane-Pretreated, HER2-Negative, Locally Recurrent or Metastatic Breast Cancer
作者
Rachel A. Borson,W. Graydon Harker,James Andrew Reeves,Thaddeus Beck,Steven Jeffrey Hager,William L. Horvath,Michael Jones,Guy W Tillinghast,Edward R. Arrowsmith,Grant Harrer,Fred J. Kudrik,Stephen C. Malamud,Jane L. Bromund,Haoyue Zeigler,Datchen Fritz Tai,Lori J. Kornberg,Coleman K. Obasaju,Mauro Orlando,Denise Aysel Yardley